A groundbreaking ceremony has taken place after pharmaceutical glass manufacturer Schott invested a total of EUR 70 million in the expansion of its Indian tubing site in Jambusar, Gujarat, following several million in investments over the last few years.
The additional tank is scheduled to go into operation at the beginning of 2023, with the second one following a year later.
The expansion in Jambusar will create new jobs for around 225 employees and is part of a more than $1 billion strategic investment program of Schott through to 2025.
Dr. Patrick Markschläger, Executive Vice President of Schott's Business Unit Tubing said: "Against the backdrop of the growth trend in the Indian pharmaceutical business and the pandemic, we want to commit to secure the supply of pharma glass."
Pawan Shukla, Managing Director Schott Glass India added: "The increase of over 30 percent in the facility's overall Indian production capacity is at the same time a commitment to supporting the government's vision of India becoming a global pharmaceutical hub."
In India, almost all approved vaccines are packed in Fiolax glass made by Schott.
With additional melting tanks and production lines, Schott intends to ensure that this Asian manufacturing hub can adequately supply pharma glass for the Indian pharma industry and neighbouring countries.
